美股市场个股详情

AGIO Agios Pharmaceuticals

添加自选

34.340
-0.660-1.89%

收盘价 05/17 16:00 (美东)

34.340
0.0000.00%

盘后 16:02 (美东)

19.50亿总市值-5442市盈率TTM

Agios Pharmaceuticals股票讨论区

登录发表评论

Meltyy

05/12 21:23

🎯 Ph 3 readouts in Q2 2024...

$美国联合医疗(UTHR.US)$ Phase 3
$Ironwood医药(IRWD.US)$ Phase 3
$Liquidia(LQDA.US)$ Phase 3
$美国联合医疗(UTHR.US)$ Phase 3
$MorphoSys(MOR.US)$ Phase 3
$Immunocore(IMCR.US)$ Phase 3
$Crinetics(CRNX.US)$ Phase 3
$乌龙制药(URGN.US)$ Phase 3
$阿斯利康(AZN.US)$ Phase 3
$阿斯利康(AZN.US)$ Phase 3
$阿斯利康(AZN.US)$ Phase 3
$阿斯利康(AZN.US)$ Phase 3
$Capricor Therapeutics(CAPR.US)$ Phase 3
$Annexon(ANNX.US)$ Phase 3
$Lipocine(LPCN.US)$ Phase 3...

Moomoo AI

2023/12/05 11:33

Despite the recent upturn, the company’s financial performance is seen as too risky due to its sustained revenue decline and loss-making status.

Strong Week for Agios Pharmaceuticals (NASDAQ:AGIO) Shareholders Doesn't Alleviate Pain of Five-year Loss

Moomoo AI

2023/11/04 07:34

Analysts are more optimistic about the company's revenue while expecting losses per share stability. They predict Agios Pharmaceuticals' growth to outpace competitors for now, despite a range of varied future estimates.

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

GemHunter

2023/11/02 09:21

Loading up my bags

$Agios Pharmaceuticals(AGIO.US)$

Moomoo AI

2023/10/28 08:39

Lack of insider buying and substantial insider selling in recent months warrants caution for shareholders regarding the company's stocks. Despite decent insider ownership, the absence of recent insider buying raises doubts about future prospects.

Several Agios Pharmaceuticals Insiders Sell Shares Sending Potential Negative Signal

Moomoo Breakfast US

2022/09/19 07:22

专栏Today's Pre-Market Stock Movers: TTWO, AZO, BLUE, PRPL and More

Gapping up
In reaction to earnings/guidance:
• $汽车地带(AZO.US)$ +2.7%, $雅各布工程(J.US)$ +0.9% (reaffirms Q4 EPS and adjusted EBITDA guidance)
Other news:
• $Purple Innovation(PRPL.US)$ +32.6% (confirms it received an unsolicited, non-binding proposal from Coliseum Capital Management to acquire all of the outstanding capital stock of Purple for $4.35 per share)
• $KnowBe4(KNBE.US)$ +24.9% (received a non-binding proposal f...

Moomoo Breakfast US

2022/08/19 07:53

专栏Today's Pre-Market Stock Movers: FL, DE, BBBY, AMC and More

Gainers:
In reaction to earnings/guidance:
• $富乐客(FL.US)$ +19.7%, $BILL Holdings(BILL.US)$ +18.1% (also names new COO), $巴克尔(BKE.US)$ +1.7%
Other news:
• $Axsome Therapeutics(AXSM.US)$ +33.8% (announces FDA approval of AUVELITY the first and only oral nmda receptor antagonist for the treatment of major depressive disorder in adults)
• $SpringWorks Therapeutics(SWTX.US)$ +4.9% (late-breaking oral presentation of phase 3 DeFi da...